Bruker (BRKR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
CEO welcomed participants to the 2026 annual meeting, highlighting the virtual format for inclusivity and introduced key executives and directors present at the meeting.
Independent auditors from PricewaterhouseCoopers, LLP were introduced as the company's public accounting firm for fiscal year 2026.
Corporate governance
Secretary confirmed proper notice of the meeting, record date, and presence of a quorum with over 96% of shares represented.
Inspector of Elections was appointed to oversee voting.
Shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting was proposed.
Advisory vote on 2025 executive compensation and ratification of PricewaterhouseCoopers, LLP as independent auditors for 2026 were presented.
Latest events from Bruker
- Q1 2026 revenue up 2.7%, EPS down, but FY guidance reaffirmed with strong bookings and cost savings.BRKR
Q1 20267 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.BRKR
Proxy filing10 Apr 2026 - 2026 proxy covers director elections, say-on-pay, auditor ratification, and robust ESG and governance.BRKR
Proxy filing10 Apr 2026 - FY26 guidance targets margin and EPS growth despite flat FY25 revenue and margin declines.BRKR
Q4 202512 Feb 2026 - Q2 2024 revenue up 17.4% as acquisitions drive growth, but margins pressured by costs.BRKR
Q2 20242 Feb 2026 - Innovation and acquisitions fuel growth in proteomics, diagnostics, and spatial biology.BRKR
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Strategic acquisitions and innovation drive strong growth and expanded market leadership.BRKR
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Operational excellence and innovation in proteomics and spatial biology drive future growth.BRKR
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Growth driven by innovation, strategic acquisitions, and a robust backlog amid evolving market dynamics.BRKR
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026